XML 52 R13.htm IDEA: XBRL DOCUMENT v3.20.1
Discontinued Operations
12 Months Ended
Dec. 31, 2019
Discontinued Operations.  
Discontinued operations

(5)Discontinued Operations

Effective December 17, 2018, the Company sold substantially all of the assets exclusively related to its ReShape Balloon product line to Apollo in connection with the Company’s acquisition of substantially all of the assets exclusively related to Apollo’s Lap-Band product line. The ReShape Balloon product line assets sold to Apollo consisted of inventory, property and equipment and the related intellectual property underlying the intangible assets. In connection with the Apollo transaction, the Company retained all other working capital associated with the ReShape Balloon product line, including accounts receivable, accounts payable and certain accrued and other liabilities arising from operations before the closing of the Apollo transaction, and there was no transfer of workforce. The ReShape Balloon product line was the primary operating activity of ReShape Medical, Inc. (“ReShape Medical”), a business the Company acquired in October 2017 and accounted for as a business combination. The purchase accounting was finalized during the fourth quarter of 2018 and did not result in any changes to the purchase price allocation. The operations of the ReShape Balloon product line are shown as discontinued operations in the accompanying Consolidated Financial Statements. See Note 4 for more information regarding the Lap-Band product line acquisition.

In the second quarter of 2018, the Company recorded an impairment charge of $13.2 million for the full write-down of the goodwill recorded in connection with its acquisition of ReShape Medical. Refer to Note 9 for additional information regarding evaluation of goodwill for impairment. In connection with the determination of the fair value of the Lap-Band assets acquired, no value was assigned to the ReShape Balloon product line assets sold as projections updated during the fourth quarter of 2018 indicated negative cash flows. Accordingly, the loss on disposal of discontinued operations consists of an impairment charge of $22.6 million for the full write-down of the ReShape Balloon product line assets disposed of, which had the following carrying values as of December 17, 2018 prior to the write-down:

 

 

 

 

Inventory

 

$

670

Property and equipment, net

 

 

42

Other intangible assets, net

 

 

21,884

 

 

$

22,596

 

There were no assets associated with the ReShape Balloon product line at December 31, 2019 and 2018.

The components of loss from discontinued operations for the year ended December 31, 2018 consisted of the following:

 

 

 

 

 

 

 

 

 

Year Ended

 

 

December 31, 2018

Revenue

 

$

2,285

Loss from discontinued operations before income taxes

 

 

(45,885)

Income tax benefit

 

 

 —

Loss from discontinued operations, net of tax

 

$

(45,885)